US2005142188A1PendingUtilityA1
Pellets having a core coated with an antifungal and a polymer
Est. expiryJul 17, 2018(expired)· nominal 20-yr term from priority
A61K 9/5078A61P 31/10A61K 9/50
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is concerned with pellets comprising a 710-1180 μm (16-25 mesh) sugar core, a coating film of a water-soluble polymer and an antifungal agent, and a seal coating layer wherein the residual concentration of dichloromethane is below 600 ppm; pharmaceutical dosage forms comprising said pellets and a method of preparing said pellets.
Claims
exact text as granted — not AI-modified1 . A pellet comprising
a) a central, rounded or spherical core having a diameter from about 710 to about 1180 μm (16-25 mesh); b) a coating film of a water-soluble polymer and an antifungal agent, and c) a seal-coating polymer layer, wherein the residual concentration of dichloromethane in said pellet is less than 600 ppm.
2 . A pellet according to claim 1 comprising approximately, by weight based on the total weight of the pellet:
a) 35 to 60 percent core material; b) 23 to 37 percent water-soluble polymer; c) 15 to 25 percent antifungal agent; and d) 2 to 4 percent seal-coating polymer.
3 . A pellet according to claim 2 wherein the core material is a 710-850 μm (20-25 mesh) sugar core, the water-soluble polymer is hydroxypropyl methylcellulose and the antifungal agent is itraconazole.
4 . A pellet according to claim 3 wherein the weight to weight ratio of antifungal agent to water-soluble polymer is about 1:1 to about 1:2.
5 . A pellet according to claim 2 wherein the seal-coating polymer is polyethylene glycol.
6 . A pellet according to claim 3 comprising approximately:
a) 40 to 43 percent sugar cores; b) 30 to 35 percent hydroxypropyl methylcellulose 2910 5 mPa.s. c) 20 to 25 percent itraconazole; and d) 2 to 4 percent polyethylene glycol 20000.
7 . A pharmaceutical dosage form comprising an effective antifungal amount of pellets as claimed in claim 1 .
8 . A dosage form according to claim 7 wherein the dosage form is a hard-gelatin capsule.
9 - 10 . (canceled)
11 . The pellet of claim 1 wherein the coating film is an irradiated coating film.
12 . The pellet of claim 11 , wherein the radiation is microwave or radiofrequency radiation.
13 . A method of treating a patient suffering from a fungal infection comprising administering a therapeutically effective amount of pellets as claimed in claim 1 .
14 . Pellets made by a process comprising:
coating sugar cores having a diameter from about 710 to about 1180 μm (16-25 mesh) by spraying them with a solution of an antifungal agent and a water-soluble polymer in an organic solvent comprising methylene chloride and an alcohol; drying the resulting coated cores in vacuo by irradiating said cores with microwave or radiofrequency radiation; and seal-coating the dried cores by spraying them with a solution of a seal-coating polymer in an organic solvent comprising methylene chloride and an alcohol, wherein said pellets have a residual concentration of dichloromethane of less than 600 ppm.
15 . The pellets of claim 14 wherein the antifungal agent is selected from itraconazole or saperconazole.
16 . The pellets of claim 15 wherein the antifungal agent is itraconazole.
17 . The pellets of claim 14 wherein the water-soluble polymer is hydroxypropyl methylcellulose and the antifungal agent is itraconazole.
18 . The pellets of claim 14 wherein the seal-coating polymer is polyethylene glycol.
19 . The pellets of claim 14 , wherein the alcohol is ethanol.Join the waitlist — get patent alerts
Track US2005142188A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.